Q-omics provides the consensus-scored DEFB130A profile across patient tissues and cancer cell-line models. Additionally, DEFB130A RNA expression shows 26 significant gene co-expression associations, with the highest sampling consensus in KIRC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for DEFB130A — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with DEFB130A in patient tissues and cancer cell lines. In patient samples, DEFB130A shows the broadest associations at the RNA and protein expression levels, with KIRC recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	26	KIRC (19)	view →
Mutation	12	HNSC (12)	view →